BIOORGANIC & MEDICINAL CHEMISTRY, published by Pergamon-Elsevier Science Ltd, is a prominent journal in the fields of biochemical research and drug discovery, with an ISSN of 0968-0896 and an E-ISSN of 1464-3391. Established in 1993, it has garnered respect and recognition, evidenced by its categorization in various quartile ranks across 2023, including Q2 in Clinical Biochemistry and Pharmaceutical Science. It holds significant Scopus rankings, placing it in the 75th percentile in Pharmaceutical Science and 74th percentile in Organic Chemistry, highlighting its influential contributions to ongoing research and developments. This journal provides a platform for disseminating advancements in bioorganic and medicinal chemistry, focusing on innovative methodologies, therapeutic advancements, and molecular pharmacology. Although it does not follow an open-access model, it remains a key resource for researchers, professionals, and students aiming to stay at the forefront of scientific discovery in the UK and beyond. The journal’s commitment to enhancing knowledge within the biomedical community makes it an essential read for those passionate about this dynamic field.

Welcome to ChemistrySelect, a pivotal journal in the field of chemistry published by WILEY-V C H VERLAG GMBH. With its ISSN 2365-6549, this journal aims to provide a comprehensive platform for researchers and practitioners to share significant advancements in various areas of chemistry, contributing to the ongoing dialogue and development within the scientific community. Since its inception in 2016, ChemistrySelect has focused on publishing high-quality research that spans multiple facets of the discipline, earning its place in the Q3 category for Chemistry (miscellaneous) as of 2023. While operating under a subscription model, the journal remains committed to broadening accessibility and engaging a wide audience of researchers, professionals, and students. The journal's objective is to facilitate the dissemination of groundbreaking findings through rigorous peer review, ensuring that the latest studies reflect the evolving nature of chemistry research. As we approach 2024, ChemistrySelect continues to be an invaluable resource for the academic community, positioning itself as a trusted voice in the world of chemical research.

Results in Chemistry is a prominent journal published by Elsevier, dedicated to fostering innovation and disseminating cutting-edge research in the field of chemistry. With an ISSN of 2211-7156, this open-access journal has been committed to making scientific knowledge widely available since 2019, aligning with the global trend towards accessibility in research. Based in the Netherlands, it features interdisciplinary studies that span the breadth of general chemistry, contributing significantly to the academic dialogue within the scientific community. Despite currently holding a Q3 ranking in the miscellaneous category of chemistry and occupying the 228th position out of 408 in Scopus rankings, the journal is poised for growth, aiming to enhance its impact and visibility. Researchers, professionals, and students alike will find invaluable resources and insights within its pages, making Results in Chemistry an essential platform for those looking to stay abreast of advancements and trends in chemistry research up to the year 2024.

ACS Bio & Med Chem Au, published by the esteemed American Chemical Society, stands at the forefront of interdisciplinary research within the realms of biochemistry, drug discovery, pharmaceutical sciences, and molecular biology. With an impressive Impact Factor indicative of its rigorous academic standards and significant contributions to the field, this open-access journal is committed to disseminating high-quality research that drives innovation and advancements in biosciences and medicinal chemistry. Since its inception in 2021, the journal has rapidly earned recognition, achieving a commendable Q1 ranking in multiple categories, including Biochemistry, Drug Discovery, and Pharmaceutical Science, while also making strides in Molecular Biology. Researchers, professionals, and students alike can explore pioneering studies that bridge gaps between laboratory research and clinical applications, fostering collaborative efforts towards novel therapeutic strategies. With a focus on enhancing accessibility and engagement within the scientific community, ACS Bio & Med Chem Au is poised to impact the future of biomedical research significantly.

Peptide Science, published by Wiley, is an esteemed journal dedicated to advancing the understanding of peptide chemistry and its applications across various scientific disciplines, including biochemistry, biophysics, and organic chemistry. Since its inception in 2018 and continuing through 2024, this journal has provided an essential platform for the dissemination of innovative research, engaging articles, and critical reviews. With an impressive Q3 ranking in the fields of Biochemistry and Biomaterials, and a Q2 status in Biophysics and Organic Chemistry as of 2023, Peptide Science acknowledges its integral role in addressing significant scientific challenges. This open-access journal ensures that findings are readily available to a global audience, fostering collaboration and knowledge sharing among researchers, professionals, and students alike. The journal exemplifies excellence in scholarly communication, making it an essential resource for anyone interested in the intricate world of peptide research.

European Journal of Medicinal Chemistry, a premier publication by Elsevier France-Editions Scientifiques Médicales Elsevier, has been at the forefront of advancing medicinal chemistry since its inception in 1974. With an impressive impact factor and ranking in the Q1 quartile across multiple categories including Drug Discovery, Medicine (miscellaneous), Organic Chemistry, and Pharmacology, this journal delivers cutting-edge research and reviews that are vital for researchers and professionals in the field. The journal’s scope encompasses the design, synthesis, and evaluation of biological activity of bioactive compounds, making it a critical resource for those looking to innovate in drug development and therapeutic strategies. Although currently not open access, subscribers can benefit from its diverse range of high-quality articles, ensuring the dissemination of knowledge in the ever-evolving landscape of medicinal chemistry. The European Journal of Medicinal Chemistry continues to play a pivotal role in shaping the future of pharmacological research and its application, thus appealing to an audience dedicated to making impactful scientific contributions.

Journal of Molecular Structure is a premier publication in the field of chemistry, offering a platform for innovative research that spans analytical, inorganic, organic chemistry, and spectroscopy. Published by Elsevier in the Netherlands, this journal is committed to advancing the understanding of molecular architecture and behavior through high-quality, peer-reviewed articles. With its impressive impact factor and a notable Scopus ranking placing it in the top quartiles among its peers, it serves as an essential resource for researchers, professionals, and students alike. The journal's open access options promote the dissemination of knowledge, ensuring that groundbreaking discoveries reach a broad audience. Established in 1967 and projected to continue through 2025, the Journal of Molecular Structure is vital for anyone engaged in the study of molecular interactions and structural analysis.

RSC Medicinal Chemistry is a pivotal journal in the realm of medicinal chemistry, published by the esteemed Royal Society of Chemistry. With a focus on innovative research that intersects various disciplines such as biochemistry, drug discovery, pharmaceutical science, and organic chemistry, this journal serves as a vital resource for researchers, professionals, and students alike. Its impressive impact factor and notable rankings—positioning it within the Q1 and Q2 quartiles across critical categories—underscore its significance in advancing knowledge and fostering collaboration within the scientific community. RSC Medicinal Chemistry is dedicated to open access, ensuring that cutting-edge findings on drug design and therapeutic applications are freely available to enhance global research efforts. With a commitment to publication excellence from 2020 to 2024, it is a prominent platform where groundbreaking ideas meet practical implications, making it indispensable for anyone committed to the forefront of medicinal advances.

International Journal of Peptide Research and Therapeutics, published by Springer, is a distinguished platform that bridges the gap between peptide research, therapeutic applications, and interdisciplinary sciences. With a focus on providing high-quality research, this journal covers a broad array of topics including analytical chemistry, biochemistry, drug discovery, and bioengineering, reflecting the essential role peptides play in modern medicine and biotechnology. The journal holds a respectable Q3 quartile ranking across its relevant fields as of 2023, underscoring its position as a noteworthy contributor to ongoing discussions in peptide science. Operating under an Open Access model, it aims to enhance the dissemination of knowledge and foster collaborative research efforts globally. Since its inception in 1996, the journal has evolved through various converged years to continue attracting submissions that push the boundaries of peptide research and its therapeutic potential. Researchers, professionals, and students are encouraged to engage with this journal to explore cutting-edge findings and contribute to the advancing field of peptide science.

Future Medicinal Chemistry is a premier journal dedicated to the rapidly evolving fields of drug discovery, pharmacology, and molecular medicine. Published by Newlands Press Ltd in the United Kingdom, this journal has garnered significant attention within the academic community, evidenced by its 2023 category rankings in Scopus, placing it in the Q2 quartile for Drug Discovery and the Q3 quartiles for both Molecular Medicine and Pharmacology. With an ISSN of 1756-8919 and an E-ISSN of 1756-8927, Future Medicinal Chemistry has been a cornerstone of scholarly discourse since its inception in 2009, continuously contributing to the advancement of knowledge and discussion in medicinal chemistry. The journal is committed to publishing high-quality, peer-reviewed research that addresses the challenges and innovations in drug development and therapeutic strategies, making it an essential resource for researchers, professionals, and students seeking to stay at the forefront of these critical fields. Engage with the latest findings and methodologies that shape the future of medicine by exploring the wealth of information offered within Future Medicinal Chemistry.